Literature DB >> 23200932

The role of BRCA1 in DNA double-strand repair: past and present.

Kevin W Caestecker1, Gerlinde R Van de Walle.   

Abstract

The breast cancer type 1 susceptibility protein (BRCA1) is involved in several important cellular pathways, including DNA damage repair, chromatin remodeling and checkpoint activation. The BRCA1 tumor suppression function has been attributed to its role in homologous recombination damage repair. In this review, historical facts concerning BRCA1, together with recent research advances regarding our understanding of the BRCA1 interacting proteins that are involved in, homologous recombination (HR) double strand break (DBS) repair and how these interacting proteins maintain chromosomal integrity, are discussed. In addition, this review poses the questions as to what extent HR repair cannot be properly fulfilled when breast cancer related mutations in the BRCA1 gene occur and how the recent and excessive studied poly-ADP ribose polymerase (PARP) inhibiting therapy approach links with the proposed tumor suppression function of the different BRCA1 domains.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200932     DOI: 10.1016/j.yexcr.2012.11.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  37 in total

1.  Curcumin inhibits PhIP induced cytotoxicity in breast epithelial cells through multiple molecular targets.

Authors:  Ashok Jain; Abhilash Samykutty; Carissa Jackson; Darren Browning; Wendy B Bollag; Muthusamy Thangaraju; Satoru Takahashi; Shree Ram Singh
Journal:  Cancer Lett       Date:  2015-05-21       Impact factor: 8.679

2.  Increased DNA damage and repair deficiency in granulosa cells are associated with ovarian aging in rhesus monkey.

Authors:  Dongdong Zhang; Xiaoqian Zhang; Ming Zeng; Jihong Yuan; Mengyuan Liu; Yu Yin; Xueqing Wu; David L Keefe; Lin Liu
Journal:  J Assist Reprod Genet       Date:  2015-05-10       Impact factor: 3.412

3.  Triple negative breast cancer: approved treatment options and their mechanisms of action.

Authors:  Aditya Mandapati; Kiven Erique Lukong
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-17       Impact factor: 4.322

4.  The role of ubiquitin signaling pathway on liver regeneration in rats.

Authors:  Ayse Ozmen Yaylaci; Mediha Canbek
Journal:  Mol Cell Biochem       Date:  2022-06-24       Impact factor: 3.396

Review 5.  Structural mechanisms underlying signaling in the cellular response to DNA double strand breaks.

Authors:  Inbal Mermershtain; J N Mark Glover
Journal:  Mutat Res       Date:  2013-07-27       Impact factor: 2.433

6.  Overexpression of Ran GTPase Components Regulating Nuclear Export, but not Mitotic Spindle Assembly, Marks Chromosome Instability and Poor Prognosis in Breast Cancer.

Authors:  Srividya Vaidyanathan; Pulari U Thangavelu; Pascal H G Duijf
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

7.  BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.

Authors:  Weixing Zhao; Justin B Steinfeld; Fengshan Liang; Xiaoyong Chen; David G Maranon; Chu Jian Ma; Youngho Kwon; Timsi Rao; Weibin Wang; Chen Sheng; Xuemei Song; Yanhong Deng; Judit Jimenez-Sainz; Lucy Lu; Ryan B Jensen; Yong Xiong; Gary M Kupfer; Claudia Wiese; Eric C Greene; Patrick Sung
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

8.  β-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation.

Authors:  Nicholas A Wallace; Kristin Robinson; Heather L Howie; Denise A Galloway
Journal:  PLoS Pathog       Date:  2015-03-24       Impact factor: 6.823

9.  Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS.

Authors:  Harun Najib Noristani; Jean Charles Sabourin; Yannick Nicolas Gerber; Marisa Teigell; Andreas Sommacal; Maria dM Vivanco; Markus Weber; Florence Evelyne Perrin
Journal:  Mol Neurodegener       Date:  2015-08-01       Impact factor: 14.195

10.  Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.

Authors:  Nada Albarakati; Tarek M A Abdel-Fatah; Rachel Doherty; Roslin Russell; Devika Agarwal; Paul Moseley; Christina Perry; Arvind Arora; Nouf Alsubhi; Claire Seedhouse; Emad A Rakha; Andrew Green; Graham Ball; Stephen Chan; Carlos Caldas; Ian O Ellis; Srinivasan Madhusudan
Journal:  Mol Oncol       Date:  2014-08-27       Impact factor: 7.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.